Unlocking the Benefits of FDA's Orphan Drug Designation : vi

Securing an orphan drug designation is no small feat, in part because the number of patients affected cannot exceed 200,000 in the United States, despite population growth over 40 years.

Related Keywords

United States , America , Rachel Capone , Office Of Orphan Products Development , Lancet Reg Health , European Union , Biopharma Group , Us Census Bureau , Research Nextgen Portal , Drug Designation , Orphan Drug Act , Orphan Products Development , Prescription Drug User , Orphan Drug , Synerg Biopharma , Drug Evaluation , Research Nextgen , Accessed August , Latin America , Reg Health , Orphan Drug Designation , Fda , Orphan Disease ,